We are live on
!
Find out more
NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
1-Year Est. Return
8.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.23%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$32.9M
AUM Growth
+$316K
(+0.97%)
Cap. Flow
-$103K
Cap. Flow
% of AUM
-0.31%
Top 10 Holdings %
Top 10 Hldgs %
39.77%
Holding
37
New
–
Increased
5
Reduced
27
Closed
–
Avg Time Held
6.9
quarters
Top 10 Avg Time Held
4.4
quarters
Top 20 Avg Time Held
5.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$2.53K |
| 2 |
Kimberly-Clark
KMB
|
+$2.21K |
| 3 |
GE Aerospace
GE
|
+$1.43K |
| 4 |
AT&T
T
|
+$1.17K |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$593 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$11K |
| 2 |
Elevance Health
ELV
|
+$10.7K |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$7.59K |
| 4 |
Markel Group
MKL
|
+$7.23K |
| 5 |
Bank of America
BAC
|
+$6.67K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.2% |
| 2 | Financials | 22.79% |
| 3 | Technology | 12.06% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Staples | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.97T
| $1.65M | 5% |
52,944
-140
| -0.3% | -$4.23K |
2013 Q2
7 quarters
|
|
2
UnitedHealth
UNH
$333B
| $1.54M | 4.69% |
13,055
-40
| -0.3% | -$4.44K |
2013 Q2
7 quarters
|
|
|
3
Elevance Health
ELV
$87B
| $1.47M | 4.47% |
9,540
-75
| -0.8% | -$10.7K |
2013 Q2
7 quarters
|
|
|
4
Markel Group
MKL
$21.9B
| $1.43M | 4.34% |
1,860
-10
| -0.5% | -$7.23K |
2013 Q4
5 quarters
|
|
5
Honeywell
HON
$65.5B
| $1.3M | 3.94% |
13,839
| – | – |
2013 Q2
7 quarters
|
|
|
6
Bank of America
BAC
$375B
| $1.16M | 3.52% |
75,336
-415
| -0.5% | -$6.67K |
2013 Q2
7 quarters
|
|
7
Johnson & Johnson
JNJ
$618B
| $1.16M | 3.51% |
11,490
-5
| -0% | -$508 |
2013 Q2
7 quarters
|
|
8
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
| $1.15M | 3.48% |
18,425
-50
| -0.3% | -$2.91K |
2013 Q2
7 quarters
|
|
9
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.13M | 3.42% |
7,805
| – | – |
2013 Q2
7 quarters
|
|
10
Pfizer
PFE
$159B
| $1.12M | 3.41% |
34,033
-110
| -0.3% | -$3.5K |
2013 Q2
7 quarters
|
|
|
11
Intel
INTC
$566B
| $1.09M | 3.31% |
34,832
+75
| +0.2% | +$2.53K |
2013 Q2
7 quarters
|
|
12
JPMorgan Chase
JPM
$881B
| $1.08M | 3.29% |
17,873
-70
| -0.4% | -$4.14K |
2013 Q2
7 quarters
|
|
13
Aon
AON
$58.8B
| $1.01M | 3.08% |
10,560
-40
| -0.4% | -$3.87K |
2013 Q2
7 quarters
|
|
14
Yum! Brands
YUM
$39B
| $1.01M | 3.07% |
17,902
| – | – |
2013 Q2
7 quarters
|
|
15
Procter & Gamble
PG
$350B
| $954K | 2.9% |
11,646
-70
| -0.6% | -$6.02K |
2013 Q2
7 quarters
|
|
|
16
Bristol-Myers Squibb
BMY
$122B
| $934K | 2.83% |
14,480
-175
| -1% | -$11K |
2013 Q2
7 quarters
|
|
|
CB
17
DELISTED
CHUBB CORPORATION
CB
| $928K | 2.82% |
9,175
-75
| -0.8% | -$7.59K |
2013 Q2
7 quarters
|
|
18
Qualcomm
QCOM
$188B
| $872K | 2.65% |
12,580
-35
| -0.3% | -$2.47K |
2013 Q2
7 quarters
|
|
|
19
Kimberly-Clark
KMB
$32.5B
| $825K | 2.5% |
7,698
+20
| +0.3% | +$2.21K |
2013 Q2
7 quarters
|
|
20
Public Service Enterprise Group
PEG
$35.8B
| $812K | 2.46% |
19,380
| – | – |
2013 Q2
7 quarters
|
|
21
Merck
MRK
$351B
| $794K | 2.41% |
14,483
-42
| -0.3% | -$2.38K |
2013 Q3
6 quarters
|
|
22
Diageo
DEO
$48.4B
| $771K | 2.34% |
6,969
-20
| -0.3% | -$2.3K |
2013 Q2
7 quarters
|
|
23
Wells Fargo
WFC
$248B
| $768K | 2.33% |
14,116
-70
| -0.5% | -$3.78K |
2013 Q2
7 quarters
|
|
24
Emerson Electric
EMR
$88.7B
| $756K | 2.29% |
13,355
-50
| -0.4% | -$2.91K |
2013 Q2
7 quarters
|
|
|
25
GE Aerospace
GE
$317B
| $718K | 2.18% |
6,040
+12
| +0.2% | +$1.43K |
2013 Q2
7 quarters
|
|
Similar funds
PRHC
BC
SCPM
SAM
BCP
AVA
GG
SM
Needelman Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Needelman Asset Management held 37 positions worth $32.9M, up 0.97% from $32.6M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 0%. Needelman Asset Management opened no new positions and made no exits, leaving the 37-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Financials and Technology.
- Needelman Asset Management added most to Intel in Q1 2015, an estimated $2.53K increase.
- Needelman Asset Management's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $11K.
- Needelman Asset Management's ten largest holdings make up 40% of its $32.9M portfolio in Q1 2015.
- Needelman Asset Management opened 0 new positions and closed 0 in Q1 2015.
- Needelman Asset Management's portfolio value rose 0.97% quarter-over-quarter to $32.9M.
Based on Needelman Asset Management's 13F filing for Q1 2015, filed 9 Apr 2015.